1. Home
  2. GENC vs RNA Comparison

GENC vs RNA Comparison

Compare GENC & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gencor Industries Inc.

GENC

Gencor Industries Inc.

HOLD

Current Price

$15.01

Market Cap

219.1M

Sector

Industrials

ML Signal

HOLD

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

HOLD

Current Price

$12.31

Market Cap

211.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GENC
RNA
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
219.1M
211.6M
IPO Year
1995
2025

Fundamental Metrics

Financial Performance
Metric
GENC
RNA
Price
$15.01
$12.31
Analyst Decision
Strong Buy
Buy
Analyst Count
1
20
Target Price
$17.60
$69.26
AVG Volume (30 Days)
29.6K
173.0K
Earning Date
02-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
8.08
N/A
EPS
0.50
N/A
Revenue
$48,943,000.00
N/A
Revenue This Year
N/A
$88.12
Revenue Next Year
$25.51
$18.11
P/E Ratio
$29.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.22
$11.40
52 Week High
$17.40
$73.06

Technical Indicators

Market Signals
Indicator
GENC
RNA
Relative Strength Index (RSI) 50.00 43.92
Support Level $14.57 $11.95
Resistance Level $15.62 $14.05
Average True Range (ATR) 0.47 0.51
MACD 0.03 0.13
Stochastic Oscillator 47.33 43.33

Price Performance

Historical Comparison
GENC
RNA

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Share on Social Networks: